Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Influence of BRCA1 Germline Mutations in the Somatic Mutational Burden of Triple-Negative Breast Cancer

Full text
Author(s):
Ferreira, Elisa Napolitano [1] ; Brianese, Rafael Canfield [1] ; Bueno de Almeida, Renan Valieris [1] ; Drummond, Rodrigo Duarte [1] ; de Souza, Jorge Estefano [2, 3] ; da Silva, Israel Tojal [1] ; de Souza, Sandro Jose [4, 3] ; Carraro, Dirce Maria [1, 5]
Total Authors: 8
Affiliation:
[1] AC Camargo Canc Ctr, Int Res Ctr, CIPE, Sao Paulo, SP - Brazil
[2] Univ Fed Rio Grande do Norte, Inst Metropole Digital, Natal, RN - Brazil
[3] Univ Fed Rio Grande do Norte, Bioinformat Multidisciplinary Environm BioME, Natal, RN - Brazil
[4] Univ Fed Rio Grande do Norte, Brain Inst, Natal, RN - Brazil
[5] Natl Inst Sci & Technol Oncogen & Therapeut Innov, Sao Paulo, SP - Brazil
Total Affiliations: 5
Document type: Journal article
Source: TRANSLATIONAL ONCOLOGY; v. 12, n. 11, p. 1453-1460, NOV 2019.
Web of Science Citations: 0
Abstract

The majority of the hereditary triple-negative breast cancers (TNBCs) are associated with BRCA1 germline mutations. Nevertheless, the understanding of the role of BRCA1 deficiency in the TNBC tumorigenesis is poor. In this sense, we performed whole-exome sequencing of triplet samples (leucocyte, tumor, and normal-adjacent breast tissue) for 10 cases of early-onset TNBC, including 5 hereditary (with BRCA1 germline pathogenic mutation) and 5 sporadic (with no BRCA1 or BRCA2 germline pathogenic mutations), for assessing the somatic mutation repertoire. Protein-affecting somatic mutations were identified for both mammary tissues, and Ingenuity Pathway Analysis was used to investigate gene interactions. BRCA1 and RAD51C somatic promoter methylation in tumor samples was also investigated by bisulfite sequencing. Sporadic tumors had higher proportion of driver mutations (>= 25% allele frequency)than BRCA1 hereditary tumors, whereas no difference was detected in the normal breast samples. Distinct gene networks were obtained from the driver genes in each group. The Cancer Genome Atlas data analysis of TNBC classified as hereditary and sporadic reinforced our findings. The data presented here indicate that in the absence of BRCA1 germline mutations, a higher number of driver mutations are required for tumor development and that different defective processes are operating in the tumorigenesis of hereditary and sporadic TNBC in young women. (AU)

FAPESP's process: 13/23277-8 - Molecular aspects involved in the development and progression of breast ductal carcinoma: investigation of carcinoma in situ progression and the role of BRCA1 mutation in the triple negative tumor
Grantee:Dirce Maria Carraro
Support Opportunities: Research Projects - Thematic Grants